Spero Therapeutics (SPRO)
(Delayed Data from NSDQ)
$1.30 USD
+0.01 (0.78%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $1.27 -0.03 (-2.31%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/11/2024
Time: -- |
9/2024 | $-0.47 | 0.00% |
Earnings Summary
For their last quarter, Spero Therapeutics (SPRO) reported earnings of -$0.33 per share, beating the Zacks Consensus Estimate of $-0.35 per share. This reflects a positive earnings surprise of 5.71%. Look out for SPRO's next earnings release expected on November 11, 2024. For the next earning release, we expect the company to report earnings of -$0.47 per share, reflecting a year-over-year decrease of 2450%.
Earnings History
Price & Consensus
Zacks News for SPRO
NovoCure (NVCR) Reports Q2 Loss, Tops Revenue Estimates
SPRO: What are Zacks experts saying now?
Zacks Private Portfolio Services